Skip to content

J. Safra Sarasin Holding AG: SW position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of J. Safra Sarasin Holding AG on SW, newest first. How the timeline and the estimate are built.

J. Safra Sarasin Holding AG held 6,889 SW shares at 2026-06-30 per its 13F-HR filed 2026-07-31.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 6,889 shares
    Change vs previous 13F -14,446 shares

    <0.01% of the 13F portfolio, value $274,527.

    13F-HR 0001890222-26-000004 filed by J. Safra Sarasin Holding AG
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F 21,335 shares
    Change vs previous 13F -4,501 shares

    0.01% of the 13F portfolio, value $849,377.

    13F-HR 0001890222-26-000003 filed by J. Safra Sarasin Holding AG
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F 25,836 shares
    Change vs previous 13F +25,836 shares

    0.02% of the 13F portfolio, value $999,078.

    13F-HR 0001890222-26-000001 filed by J. Safra Sarasin Holding AG
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-03-31
    13F 0 shares
    Change vs previous 13F -28,202 shares

    13F-HR 0001890222-25-000002 filed by J. Safra Sarasin Holding AG
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

    Exited: the 13F for this period no longer lists the position.

  5. period ended2024-12-31
    13F 28,202 shares
    Change vs previous 13F not available

    0.03% of the 13F portfolio, value $1,518,960.

    13F-HR 0002056555-25-000002 filed by J. Safra Sarasin Holding AG
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).